HB 1292-FN (2026): expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1292-FN (2026): expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.” Granite Record, https://graniterecord.org/bill/2026/hb1292. Accessed 19 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1292-FN (2026): expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act. Retrieved 19 Oct. 2026, from https://graniterecord.org/bill/2026/hb1292
- Chicago
- Granite Record. “HB 1292-FN (2026): expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.” Accessed 19 Oct. 2026. https://graniterecord.org/bill/2026/hb1292.
- BibTeX
@misc{bill-2026-hb1292, title = {HB 1292-FN (2026): expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2026/hb1292}, note = {Accessed 19 Oct. 2026} }
HB 1292-FN (2026)
expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.
- Status: Referred for interim study
- Term: 2025-2026
- House committee: Judiciary
- Subject: Public and Mental Health
The Story
It was introduced on January 7, 2026 and referred to the House Judiciary committee. The committee held a public hearing on February 11, 2026, with 154 people signed in online: 146 in support and 8 in opposition. The committee met in executive session on February 13, 2026 to vote on its recommendation. The committee voted 17–1 to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On March 5, 2026 the House voted to study it after the session ends on a voice vote. The committee met in executive session on September 30, 2026 to vote on its recommendation. On October 5, 2026 the committee reported back on its interim study of the bill: “Recommended for Future Legislation”, by a vote of 7 to 6.
Sponsors
- Rep. Erica Layon (R - Rock 13) (prime sponsor)
- Rep. Cyril Aures (R - Merr 13)
- Rep. Sayra DeVito (R - Rock 8)
- Rep. Dan McGuire (R - Merr 14)
- Sen. Keith Murphy (R - SD16)
- Rep. Mary Murphy (R - Hills 27)
- Rep. Yury Polozov (R - Merr 10)
- Rep. Daniel Popovici-Muller (R - Rock 17)
- Rep. Matt Sabourin dit Choinière (R - Rock 30)
- Sen. Victoria Sullivan (R - SD18)
Hearings and Sessions
- February 11, 2026, 1:00 PM: public hearing, House Judiciary, GP 230
- February 13, 2026, 10:00 AM: executive session, House Judiciary, GP 158
- March 5, 2026: consent calendar, House
- September 30, 2026, 10:00 AM: executive session, House Judiciary, GP 230
Votes
- March 5, 2026, House: Refer for Interim Study — voice vote, passed
The Docket
- January 7, 2026: Introduced 01/07/2026 and referred to Judiciary
- February 11, 2026: Public Hearing: 02/11/2026 01:00 pm GP 230
- February 13, 2026: Executive Session: 02/13/2026 10:00 am GP 158
- February 13, 2026: Committee Report: Refer for Interim Study 02/13/2026 (Vote 17-1; CC)
- March 5, 2026: Refer for Interim Study: MA VV 03/05/2026
- September 30, 2026: Executive Session: 09/30/2026 10:00 am GP 230
- October 5, 2026: Interim Study Report: Recommended for Future Legislation 10/05/2026 (Vote 7-6; )
Laws It Would Change
Related Bills
- HB 701-FN (2025): relative to the terminal patients' right to try act.